About Us
MTI-GlobalStem Company Overview
GlobalStem is the commercial research products and services division of Molecular Transfer, Inc. (MTI-GlobalStem). During the summer of 2002, a small group of highly experienced biotechnology professionals left Invitrogen/LIFE to launch Molecular Transfer, Inc. (MTI) with the vision of providing superior products in the area of transformation and transfection reagents. The founding scientific members of this team have a history of innovation and success in the development of leading-edge technologies in this arena. They led the development and pioneering commercialization of virtually all of the offerings in the famous *DH5α™, DH10B™, and Lipofectamine™ families of products during their tenure with Invitrogen, and formerly, Life Technologies/BRL.
At the end of 2009 MTI acquired GlobalStem to bring together proven experts in transfection and stem cell biology giving MTI an advantage in the market. View Press Release.
The mission of GlobalStem is to advance stem cell and neurobiology research by supplying scientists with the necessary tools and reagents needed to work more efficiently and obtain reliable results faster. Stem cells, particularly pluripotent stem cells, are a notoriously labile cell type. Without careful attention, these cells tend to spontaneously differentiate and undergo genomic rearrangements in culture. Few products are currently available specifically for human embryonic stem cells. By utilizing the skills and experience of a team of highly specialized stem cell scientists, GlobalStem is filling the gap with stem-cell-optimized and -qualified growth media, sera, feeder cells, supplements, growth factors and assay kits.
*Ultrapure™, Lipofectin™ and Lipofectamine™ are trademarks of Life Technologies/Invitrogen Corporation.